National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA.
Methods Mol Biol. 2022;2474:29-38. doi: 10.1007/978-1-0716-2213-1_4.
The constitutive androstane receptor (CAR, NR1I3) controls the transcription of numerous hepatic drug metabolizing enzymes and transporters. There are two possible methods of activation for CAR, direct ligand binding and a ligand-independent method, which makes this a unique nuclear receptor. Both mechanisms require the translocation of CAR from the cytoplasm into the nucleus. Interestingly, CAR is constitutively active and spontaneously localized in the nucleus of most immortalized cell lines. This creates an important challenge in most in vitro assay models because immortalized cells cannot be used without inhibiting the high basal activity. In this book chapter, we go into detail of how to perform quantitative high-throughput screens to identify human CAR modulators through the employment of a double stable cell line. Using this line, we can identify activators, as well as deactivators, of the challenging nuclear receptor, CAR.
组成型雄烷受体 (CAR,NR1I3) 控制着许多肝药物代谢酶和转运体的转录。CAR 有两种可能的激活方式,即直接配体结合和非配体依赖的方法,这使其成为一种独特的核受体。这两种机制都需要 CAR 从细胞质易位到细胞核。有趣的是,CAR 是组成型激活的,并且在大多数永生化细胞系的细胞核中自发定位。这在大多数体外测定模型中带来了一个重要的挑战,因为如果不抑制高基础活性,就不能使用永生化细胞。在本章中,我们详细介绍了如何通过使用双稳定细胞系进行定量高通量筛选来鉴定人类 CAR 调节剂。使用该系,我们可以鉴定具有挑战性的核受体 CAR 的激活剂和失活剂。